1. Home
  2. PRAX vs PUMP Comparison

PRAX vs PUMP Comparison

Compare PRAX & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • PUMP
  • Stock Information
  • Founded
  • PRAX 2015
  • PUMP 2007
  • Country
  • PRAX United States
  • PUMP United States
  • Employees
  • PRAX N/A
  • PUMP N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • PUMP Oilfield Services/Equipment
  • Sector
  • PRAX Health Care
  • PUMP Energy
  • Exchange
  • PRAX Nasdaq
  • PUMP Nasdaq
  • Market Cap
  • PRAX 599.7M
  • PUMP 550.9M
  • IPO Year
  • PRAX 2020
  • PUMP 2017
  • Fundamental
  • Price
  • PRAX $38.55
  • PUMP $5.40
  • Analyst Decision
  • PRAX Strong Buy
  • PUMP Buy
  • Analyst Count
  • PRAX 10
  • PUMP 5
  • Target Price
  • PRAX $116.50
  • PUMP $9.75
  • AVG Volume (30 Days)
  • PRAX 320.6K
  • PUMP 1.4M
  • Earning Date
  • PRAX 05-02-2025
  • PUMP 04-29-2025
  • Dividend Yield
  • PRAX N/A
  • PUMP N/A
  • EPS Growth
  • PRAX N/A
  • PUMP N/A
  • EPS
  • PRAX N/A
  • PUMP N/A
  • Revenue
  • PRAX $8,122,000.00
  • PUMP $1,397,859,000.00
  • Revenue This Year
  • PRAX N/A
  • PUMP N/A
  • Revenue Next Year
  • PRAX N/A
  • PUMP $9.04
  • P/E Ratio
  • PRAX N/A
  • PUMP N/A
  • Revenue Growth
  • PRAX 270.02
  • PUMP N/A
  • 52 Week Low
  • PRAX $26.70
  • PUMP $4.61
  • 52 Week High
  • PRAX $91.83
  • PUMP $11.17
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 53.72
  • PUMP 44.36
  • Support Level
  • PRAX $35.21
  • PUMP $5.27
  • Resistance Level
  • PRAX $38.90
  • PUMP $5.74
  • Average True Range (ATR)
  • PRAX 2.09
  • PUMP 0.23
  • MACD
  • PRAX 0.07
  • PUMP 0.00
  • Stochastic Oscillator
  • PRAX 69.58
  • PUMP 14.24

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.

Share on Social Networks: